what is the base of the development of weight-reduction therapeutic agents?
Targeting the complex peripheral and central signals involved in weight regulation
Cholecystokinin (CCK) secretion responsible organs
- duodenum
- jejunum
cck receptors
cck a
cck b
CCK levels
plasma levels rise within 15 min
cck physiology or effects
- reduce food intake and in response to meal initiation
- local regulatory
- stimulation of gallbladder contraction
- inhibition of gastric emptying
cck drug effects
- reduce food intake (meal size and duration)
- increases in meal frequency
- development of tolerance
- short half-life of the peptide
- hold minimal promise as a future antiobesity tool
ghrelin secretion organs
stomach
ghrelin receptors
- Binds to the growth hormone secretagogue receptor (GHSR)
- in the hypothalamus and brain stem
- Signaling mechanisms
(ARC) and (NPY)/ (AgRP)
expressing neurons
ghrelin levels
- Obese >fasting ghrelin levels lower following diet-induced weight loss
- obese > post-prandial fall in circulating ghrelin levels
ghrelin sc injection effects
- induce appetite
- increase food intake
ghrelin drugs
- pre-prandial receptor blockade
- NPY and AgRP antagonists
pp secretion organs
- endocrine pancreas
- colon
- rectum
pp receptors
- hypothalamic arcute nucleus (ARC) > Y4 receptors
- increase endogenous PP production
- avoiding degradation in the circulation,
- increase Y4-mediated signaling
pp levels
- low > during the fasting
- rise > in proportion to caloric intake
pp drug effects
- reduction in appetite
- reduction food intake
pyy secretion organs
L-cells of the GI tract
pyy receptor
- Y family of G protein-coupled receptor
- preferentiality for the Y2 receptor
pyy levels
- influenced by meal composition and calorie content
- elevated within 1 h post-feeding
- often lower in the obese state
ppy drug
- Inhibition of food intake > selective Y2 agonist
- attenuation of this inhibitory effect > Y2 antagonists
- IV PYY3-36 > decrease in appetite and 30% restriction in caloric intake
GLP-1 secretion organ
small intestinal and colonic L-cells
GLP 1 receptor
GLP 1 R
GLP 1 levels in obese patients
- delays in the post-prandial release
- reduced circulating levels of the peptide
GLP 1 drug
- anorexigenic effects
- influences on food intake
- reduction in gastric emptying
- suppression of gastric acid secretion
- GLP-1 or GLP-1 receptor agonists > satiety, reduce food intake, weight loss
GLP 1 limitation to its possible therapeutic utility
- inactivation and clearance by (DPP-IV)
- short half-life of GLP-1 > 5 min
Oxyntomodulin (OXM) secretion organ
intestinal L cells
OXM receptor
GLP 1 R
OXM drug
- increases satiation and reduces food intake
- decreases in body weight
- increased energy expenditure
leptin secretion
white adipose tissue adipocytes
leptin levels in obesity
- proportional to fat mass
- increased circulating leptin levels
- lack of leptinmediated effects
- leptin resistance > Receptor overstimulation > negative feedback loops > block leptin signaling
leptin effects
- inhibit the orexigenic NPY/AgRP
- stimulate the anorexigenic POMC
- within the hypothalamic arcuate nucleus
leptin drug effects
- reduce food intake
- reduce body weight
- increase energy expenditure
leptin vs insulin
- central effects on food intake and energy homeostasis are less efficient
- insulin > stimulate the synthesis and secretion
of
leptin > through a feedback loop (adipoinsular axis) - Common hypothalamic targets
- crosstalk between the two hormones
insulin levels
- proportional to the degree of adiposity
Integration of Satiation and Adiposity Signals
- meals are initiated > non-homeostatic influences
- meal termination > satiation signals
- The efficacy of satiation signals varies with the amount of fat in the body as signaled to the brain by leptin and insulin
Integration of Satiation and Adiposity Signals - food restricted & loses weight
- leptin and insulin secretion both decline
- reduced adiposity signal reaches the arcuate nucleus
- lowers sensitivity to satiation signals
- more food is eaten during meals before satiation
Integration of Satiation and Adiposity Signals - Individuals who have overeaten and gained weight
- have elevated levels of adiposity signals
- enhanced sensitivity to satiation signals
- reducing the trajectory of weight gain or even promoting weight loss
- low doses of leptin or insulin are infused directly into the brain near the arcuate nucleus
- enhance satiation signals to reduce food intake